Laserfiche WebLink
<br />FY 2006 HOMELAND SECURITY GRANT PROGRAM - DECEMBER 2, 2005 <br /> <br />. Identify agent antidotes by types and dosage volumes and planning for storage, dispersal, <br />and dispensing, and awareness of how agent antidote dosages may impact the health of <br />vulnerable populations (e.g., immune-suppressed individuals, children). <br />. Ensure that alternate medical treatment facilities have immediately available electric <br />power, water and sewer, environmental controls, and other necessary infrastructure <br />support to become operationally viable on short notice. <br /> <br />CF A 2 - Strengthen Mass Prophylaxis <br />This CF A links to the Mass Prophylaxis Target Capability. MMRS jurisdictions should ensure <br />that all sources of medicines and medical supplies (e.g., MMRS cache, CHEMPACK, and <br />HRSA-funded hospital-based caches), necessary to protect first responders and first receivers <br />and support their continued operations in hazardous environments, and to provide mass <br />prophylaxis, are aggregated into a NIMS-compliant master resource list and management <br />system, in support of a mass prophylaxis distribution plan, which also addresses SNS provided <br />items, for their Operational Area. The provisions of former CF A 8, "Pharmaceutical Cache <br />Management and Status Reporting" are also incorporated into this CF A. <br /> <br />In support ofCDC's Cities Readiness Initiative, all MMRS jurisdictions which are in Urban <br />Areas must update their mass prophylaxis plans to be able to provide for the distribution of <br />pharmaceuticals to their entire population within 48 hours of receiving an allocation from the <br />Strategic National Stockpile. In addition, all MMRS jurisdictions must maintain on file an <br />inventory of the MMRS local pharmaceutical cache, in Microsoft@Excel format, to be provided <br />electronically to DHS upon request. This inventory must include the following data elements: <br /> <br />· Pharmaceutical products contained and inventory of jurisdiction's pharmaceutical cache <br />in units of dosage. <br />. Names and official titles of individuals authorized to release cache pharmaceuticals. <br />. Each product's Lot Number, cost, and expiration date. <br />. Pharmaceutical storage management and conditions, including percentage stored in <br />hospitals and other fixed facilities, and percentage forward-deployed on emergency <br />responder vehicles. <br /> <br />CF A 3 - Strengthen CBRNE Detection, Response, and Decontamination Capabilities <br />This CFA links to the WMD/Hazardous Materials Response and Decontamination Target <br />Capability. Elements ofMMRS baseline capabilities in CBRNE response plans are applicable to <br />this CF A. The decontamination items in CF A I, above, also apply to this CF A. <br /> <br />CF A 4 - Strengthen Interoperable Communications Capabilities <br />This CFA links to the Interoperable Communications Target Capability. In consideration of <br />Katrina/Rita after-action lessons learned, in addition to the interoperable communications <br />guidance provided in the general section of this grant guidance, in each MMRS Operational <br />Area, there must be established a Minimum Essential Emergency Medical Communications <br />Network (MEEMCN) capable of processing voice and data communications which is not <br />dependent on the Public Switched Network, avoiding to the maximum extent possible reliance <br />on terrestrial fixed site components which are vulnerable to disruption or destruction by terrorist <br />act or natural disaster. The MEEMCN shall, at a minimum, include selected medical treatment <br /> <br />PREPAREDNESS DIRECTORATE'S OFFICE OF GRANTS AND TRAINING <br /> <br />97 <br /> <br />